June 29, 2018

The shareholders of QuiaPEG Pharmaceuticals Holding AB (publ) have held an extraordinaryshareholders’meeting on June 29, 2018.The shareholders’ meeting resolved to, among othersthings, in accordance with the board ofdirectors’proposal, introduce an incentive program by way of issue of a maximum of 1 000 000 warrants to the wholly-owned subsidiary QuiaPEG Pharmaceuticals AB and to authorize the transfer of such warrants to management and others key personnel in the company and its subsidiary. The warrants are issued without consideration.

Download press release (PDF)
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
+46 (0) 70 693 12 53

User terms & privacy policy
Send a message